Back to GILD

GILEAD SCIENCES, INC. SG&A Expense 2007-2026 | GILD

Beta

What is sg&a expense?

Selling, general, and administrative expenses include all non-production costs such as marketing, corporate overhead, and management salaries.

What is GILEAD SCIENCES, INC.'s current sg&a expense?

GILEAD SCIENCES, INC. (GILD) annual sg&a expense for 2025 was $5.77B, a 5.20% decline from 2024. GILEAD SCIENCES, INC. sg&a expense for the quarter ending March 31, 2026 was $1.45B.

What was GILEAD SCIENCES, INC.'s sg&a expense in 2024?

GILEAD SCIENCES, INC. annual sg&a expense for 2024 was $6.09B, a 0.02% increase from 2023.

What was GILEAD SCIENCES, INC.'s sg&a expense in 2023?

GILEAD SCIENCES, INC. annual sg&a expense for 2023 was $6.09B, a 7.35% increase from 2022.

What is GILEAD SCIENCES, INC.'s 5-year sg&a expense CAGR?

GILEAD SCIENCES, INC. sg&a expense grew at a compound annual growth rate (CAGR) of 2.31% from FY2020 to FY2025, going from $5.15B to $5.77B over 5 years.

SG&A Expense History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+2.3%
FY2020
$5.15B
→
FY2025
$5.77B
07080910111213141516171819202122232425
5 years selected
SG&A Expense History
PeriodValueChangeSource
FY2025$5.77B-5.2%10-K
FY2024$6.09B+0.0%10-K
FY2023$6.09B+7.4%10-K
FY2022$5.67B+8.1%10-K
FY2021$5.25B+1.8%10-K
FY2020$5.15B+17.6%10-K
FY2019$4.38B+8.0%10-K
FY2018$4.06B+4.6%10-K
FY2017$3.88B+14.1%10-K
FY2016$3.40B-0.8%10-K
FY2015$3.43B+14.9%10-K
FY2014$2.98B+75.6%10-K
FY2013$1.70B+16.3%10-K
FY2012$1.46B+17.6%10-K
FY2011$1.24B+18.9%10-K
FY2010$1.04B+10.3%10-K
FY2009$946.7M+18.7%10-K
FY2008$797.3M+13.0%10-K
FY2007$705.7M-10-K
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →